NeuroMetrix, Inc. Announces Date for 2011 Fourth Quarter Financial Results Conference CallWALTHAM, Mass.--(BUSINESS WIRE)--Feb. 10, 2012--
NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2011
fourth quarter financial results before the opening of the market on
February 15, 2012. The Company will host a conference call at
8:00 a.m.,
Eastern Time on
February 15, 2012 to discuss its fourth quarter
financial results as well as business developments affecting the Company.
The conference call may be accessed in the United States by dialing
866-277-1182 and using the confirmation code 83635363. Internationally,
the conference call may be accessed by dialing 617-597-5359 and using
the same confirmation code. The earnings press release and accompanying
condensed financial statements will be accessible from the Company's
website at www.neurometrix.com
under the "Investors" tab.
A replay of the conference call will be available starting two hours
after the call by dialing 888-286-8010, domestically and 617-801-6888,
internationally. The confirmation code to access the replay is 32797063.
The replay will be available for three months after the conference call.
About NeuroMetrix
NeuroMetrix is a medical device company focused on the diagnosis and
treatment of the neurological complications of diabetes. The Company
currently markets products for the detection, diagnosis, and monitoring
of diabetic neuropathies such as diabetic peripheral neuropathy and
median neuropathy (carpal tunnel syndrome). For more information, please
visit http://www.neurometrix.com.
Source: NeuroMetrix, Inc.
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
Chief
Financial Officer
neurometrix.ir@neurometrix.com
